These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37112552)

  • 1. Per- and Polyfluoroalkyl Substances and Breastfeeding as a Vulnerable Function: A Systematic Review of Epidemiological Studies.
    Timmermann A; Avenbuan ON; Romano ME; Braun JM; Tolstrup JS; Vandenberg LN; Fenton SE
    Toxics; 2023 Mar; 11(4):. PubMed ID: 37112552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration.
    Friedman C; Dabelea D; Keil AP; Adgate JL; Glueck DH; Calafat AM; Starling AP
    Environ Epidemiol; 2023 Aug; 7(4):e260. PubMed ID: 37545807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma per- and polyfluoroalkyl substance mixtures during pregnancy and duration of breastfeeding in the New Hampshire birth cohort study.
    Romano ME; Gallagher LG; Price G; Crawford KA; Criswell R; Baker E; Botelho JC; Calafat AM; Karagas MR
    Int J Hyg Environ Health; 2024 May; 258():114359. PubMed ID: 38521049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
    Rokoff LB; Wallenborn JT; Harris MH; Rifas-Shiman SL; Criswell R; Romano ME; Young JG; Calafat AM; Oken E; Sagiv SK; Fleisch AF
    Sci Total Environ; 2023 Sep; 891():164724. PubMed ID: 37290653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis.
    Gui SY; Qiao JC; Xu KX; Li ZL; Chen YN; Wu KJ; Jiang ZX; Hu CY
    J Expo Sci Environ Epidemiol; 2023 Jan; 33(1):40-55. PubMed ID: 35970987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review protocol.
    DeLuca NM; Angrish M; Wilkins A; Thayer K; Cohen Hubal EA
    Environ Int; 2021 Jan; 146():106308. PubMed ID: 33395950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis.
    Costello E; Rock S; Stratakis N; Eckel SP; Walker DI; Valvi D; Cserbik D; Jenkins T; Xanthakos SA; Kohli R; Sisley S; Vasiliou V; La Merrill MA; Rosen H; Conti DV; McConnell R; Chatzi L
    Environ Health Perspect; 2022 Apr; 130(4):46001. PubMed ID: 35475652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to perfluoroalkyl and polyfluoroalkyl substances and risk of stroke in adults: a meta-analysis.
    Chang MC; Chung SM; Kwak SG
    Rev Environ Health; 2023 Sep; ():. PubMed ID: 37656598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Exposure to Per- and Polyfluoroalkyl Substances and Birth Outcomes: A Systematic Review and Meta-Analysis.
    Gui SY; Chen YN; Wu KJ; Liu W; Wang WJ; Liang HR; Jiang ZX; Li ZL; Hu CY
    Front Public Health; 2022; 10():855348. PubMed ID: 35400049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health evaluation of PFAS exposures and breastfeeding: a systematic literature review.
    Hoadley L; Watters M; Rogers R; Siegmann Werner L; Markiewicz KV; Forrester T; McLanahan ED
    Toxicol Sci; 2023 Jul; 194(2):121-137. PubMed ID: 37228093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue.
    LaKind JS; Naiman J; Verner MA; Lévêque L; Fenton S
    Environ Res; 2023 Feb; 219():115042. PubMed ID: 36529330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense Child Cohort.
    Højsager FD; Sigvaldsen A; Andersen MS; Juul A; Nielsen F; Möller S; Christesen HBT; Grøntved A; Grandjean P; Jensen TK
    Environ Int; 2023 Nov; 181():108264. PubMed ID: 37864903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.